ANNX
Price
$2.51
Change
-$0.04 (-1.57%)
Updated
Jul 25 closing price
Capitalization
275.38M
22 days until earnings call
TRML
Price
$19.77
Change
+$1.02 (+5.44%)
Updated
Jul 25 closing price
Capitalization
507.86M
Interact to see
Advertisement

ANNX vs TRML

Header iconANNX vs TRML Comparison
Open Charts ANNX vs TRMLBanner chart's image
Annexon
Price$2.51
Change-$0.04 (-1.57%)
Volume$765.03K
Capitalization275.38M
Tourmaline Bio
Price$19.77
Change+$1.02 (+5.44%)
Volume$246.52K
Capitalization507.86M
ANNX vs TRML Comparison Chart in %
Loading...
ANNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANNX vs. TRML commentary
Jul 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANNX is a Hold and TRML is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 28, 2025
Stock price -- (ANNX: $2.51 vs. TRML: $19.77)
Brand notoriety: ANNX and TRML are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANNX: 49% vs. TRML: 109%
Market capitalization -- ANNX: $275.38M vs. TRML: $507.86M
ANNX [@Biotechnology] is valued at $275.38M. TRML’s [@Biotechnology] market capitalization is $507.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANNX’s FA Score shows that 1 FA rating(s) are green whileTRML’s FA Score has 1 green FA rating(s).

  • ANNX’s FA Score: 1 green, 4 red.
  • TRML’s FA Score: 1 green, 4 red.
According to our system of comparison, TRML is a better buy in the long-term than ANNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANNX’s TA Score shows that 2 TA indicator(s) are bullish while TRML’s TA Score has 5 bullish TA indicator(s).

  • ANNX’s TA Score: 2 bullish, 6 bearish.
  • TRML’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, TRML is a better buy in the short-term than ANNX.

Price Growth

ANNX (@Biotechnology) experienced а +8.19% price change this week, while TRML (@Biotechnology) price change was +6.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

ANNX is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRML($508M) has a higher market cap than ANNX($275M). TRML YTD gains are higher at: -2.515 vs. ANNX (-51.072). TRML has higher annual earnings (EBITDA): -98.41M vs. ANNX (-180.76M). ANNX has more cash in the bank: 264M vs. TRML (249M). TRML has less debt than ANNX: TRML (196K) vs ANNX (28.3M). ANNX (0) and TRML (0) have equivalent revenues.
ANNXTRMLANNX / TRML
Capitalization275M508M54%
EBITDA-180.76M-98.41M184%
Gain YTD-51.072-2.5152,031%
P/E RatioN/AN/A-
Revenue00-
Total Cash264M249M106%
Total Debt28.3M196K14,439%
TECHNICAL ANALYSIS
Technical Analysis
ANNXTRML
RSI
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
86%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 5 days ago
85%
Declines
ODDS (%)
Bearish Trend 10 days ago
89%
Bearish Trend 7 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 3 days ago
86%
Aroon
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ANNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TVRRX85.010.79
+0.94%
Thornburg Small/Mid Cap Core R5
MNDFX8.660.05
+0.58%
Manning & Napier Disciplined Value I
HLQVX20.780.08
+0.39%
JPMorgan Large Cap Value I
THOGX44.850.07
+0.16%
Thornburg Global Opportunities R6
PSUYX10.17N/A
N/A
Victory Pioneer Global Value Y

ANNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANNX has been loosely correlated with IDYA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ANNX jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANNX
1D Price
Change %
ANNX100%
-1.57%
IDYA - ANNX
47%
Loosely correlated
-1.33%
OCUL - ANNX
47%
Loosely correlated
+2.43%
ZYME - ANNX
45%
Loosely correlated
-4.85%
ERAS - ANNX
44%
Loosely correlated
+1.75%
TRML - ANNX
43%
Loosely correlated
+5.44%
More

TRML and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRML has been loosely correlated with STOK. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if TRML jumps, then STOK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRML
1D Price
Change %
TRML100%
+5.44%
STOK - TRML
48%
Loosely correlated
-3.03%
IMNM - TRML
47%
Loosely correlated
-3.29%
SYRE - TRML
44%
Loosely correlated
+1.08%
ANNX - TRML
44%
Loosely correlated
-1.57%
IDYA - TRML
43%
Loosely correlated
-1.33%
More